389
Views
13
CrossRef citations to date
0
Altmetric
Articles

Drug-drug interaction prediction using PASS

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, & ORCID Icon show all
Pages 655-664 | Received 17 Jul 2019, Accepted 06 Aug 2019, Published online: 04 Sep 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

A.S. Kolodnitsky, N.S. Ionov, A.V. Rudik, A.A. Lagunin, D.A. Filimonov & V.V. Poroikov. (2023) MDM-Pred: a freely available web application for predicting the metabolism of drug-like compounds by the gut microbiota. SAR and QSAR in Environmental Research 34:5, pages 383-393.
Read now

Articles from other publishers (12)

Tooba Abdizadeh. (2023) Identification of novel potential inhibitors of monkeypox virus thymidine kinase using molecular docking, molecular dynamics simulation and MM/PBSA methods. Molecular Diversity.
Crossref
Anshika Gupta, Shweta Singh Chauhan, Anamika Singh Gaur & Ramakrishnan Parthasarathi. (2022) Computational screening for investigating the synergistic regulatory potential of drugs and phytochemicals in combination with 2-deoxy-D-glucose against SARS-CoV-2. Structural Chemistry 33:6, pages 2179-2193.
Crossref
Victoria V. Shumyantseva, Polina I. Koroleva, Tatiana V. Bulko, Gennady V. Sergeev & Sergei A. Usanov. (2022) Predicting drug–drug interactions by electrochemically driven cytochrome P450 3A4 reactions. Drug Metabolism and Personalized Therapy 37:3, pages 241-248.
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology 647 659 .
Gang Li, Bowen Yi, Jingtong Liu, Xiaoquan Jiang, Fulu Pan, Wenning Yang, Haibo Liu, Yang Liu & Guopeng Wang. (2021) Effect of CYP3A4 Inhibitors and Inducers on Pharmacokinetics and Pharmacodynamics of Saxagliptin and Active Metabolite M2 in Humans Using Physiological-Based Pharmacokinetic Combined DPP-4 Occupancy. Frontiers in Pharmacology 12.
Crossref
Matheus Nunes da Rocha, Daniela Ribeiro Alves, Marcia Machado Marinho, Selene Maia de Morais & Emmanuel Silva Marinho. (2021) Virtual Screening of Citrus Flavonoid Tangeretin: A Promising Pharmacological Tool for the Treatment and Prevention of Zika fever and COVID-19. Journal of Computational Biophysics and Chemistry 20:03, pages 283-304.
Crossref
Alexander V. Dmitriev, Anastassia V. Rudik, Dmitry A. Karasev, Pavel V. Pogodin, Alexey A. Lagunin, Dmitry A. Filimonov & Vladimir V. Poroikov. (2021) In Silico Prediction of Drug–Drug Interactions Mediated by Cytochrome P450 Isoforms. Pharmaceutics 13:4, pages 538.
Crossref
P. I. Koroleva, A. V. Kuzikov, R. A. Masamrekh, D. A. Filimonov, A. V. Dmitriev, M. G. Zaviyalova, S. M. Rikova, E. V. Shich, A. A. Makhova, T. V. Bulko, A. A. Gilep & V. V. Shumyantseva. (2021) Modeling of Drug-Drug Interactions between Omeprazole and Erythromycin in the Cytochrome P450-Dependent System In vitro. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 15:1, pages 62-70.
Crossref
Liyun Zhang, Xiaoqing Xu, Sara Badawy, Awais Ihsan, Zhenli Liu, Changqing Xie, Xu Wang & Yanfei Tao. (2020) A Review: Effects of Macrolides on CYP450 Enzymes. Current Drug Metabolism 21:12, pages 928-937.
Crossref
P.I. Koroleva, A.V. Kuzikov, R.A. Masamrekh, D.A. Filimonov, A.V. Dmitriev, M.G. Zaviyalova, S.M. Rikova, E.V. Shich, A.A. Makhova, T.V. Bulko, A.A. Gilep & V.V. Shumyantseva. (2020) Modeling of drug-drug interactions between omeprazole and erythromycin with cytochrome P450 3A4 in vitro assay. Biomeditsinskaya Khimiya 66:3, pages 241-249.
Crossref
V. V. Poroikov, D. A. Filimonov, T. A. Gloriozova, A. A. Lagunin, D. S. Druzhilovskiy, A. V. Rudik, L. A. Stolbov, A. V. Dmitriev, O. A. Tarasova, S. M. Ivanov & P. V. Pogodin. (2020) Computer-aided prediction of biological activity spectra for organic compounds: the possibilities and limitations. Russian Chemical Bulletin 68:12, pages 2143-2154.
Crossref
Dmitriev, Filimonov, Lagunin, Karasev, Pogodin, Rudik & Poroikov. (2019) Prediction of Severity of Drug-Drug Interactions Caused by Enzyme Inhibition and Activation. Molecules 24:21, pages 3955.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.